Clinical Trial Update: Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial results for armodafinil (CEP-10953) in treating narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea
• Shift Work Sleep Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Narcolepsy, Sleep Apnea, Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2010-02-22